ANGPTL4 and breast carcinoma: In 2013, Adhikary et al. reported that the repression of ANGPTL4 gene transcription resulted in the inhibition of breast cancer cell invasion in vitro, suggesting the potential role of ANGPTL4 as a therapeutic target for breast cancer [7].